APLS
Price
$17.49
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.18B
7 days until earnings call
CRSP
Price
$39.10
Change
+$0.56 (+1.45%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.39B
18 days until earnings call
Ad is loading...

APLS vs CRSP

Header iconAPLS vs CRSP Comparison
Open Charts APLS vs CRSPBanner chart's image
Apellis Pharmaceuticals
Price$17.49
Change-$0.00 (-0.00%)
Volume$72.5K
Capitalization2.18B
CRISPR Therapeutics AG
Price$39.10
Change+$0.56 (+1.45%)
Volume$41.27K
Capitalization3.39B
APLS vs CRSP Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. CRSP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and CRSP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (APLS: $17.49 vs. CRSP: $38.54)
Brand notoriety: APLS and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 86% vs. CRSP: 86%
Market capitalization -- APLS: $2.18B vs. CRSP: $3.39B
APLS [@Biotechnology] is valued at $2.18B. CRSP’s [@Biotechnology] market capitalization is $3.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLS and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 3 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both APLS and CRSP are a good buy in the short-term.

Price Growth

APLS (@Biotechnology) experienced а -3.69% price change this week, while CRSP (@Biotechnology) price change was +2.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

APLS is expected to report earnings on Aug 11, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.39B) has a higher market cap than APLS($2.18B). CRSP YTD gains are higher at: -2.083 vs. APLS (-45.190). APLS has higher annual earnings (EBITDA): -154.53M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. APLS (411M). CRSP has less debt than APLS: CRSP (224M) vs APLS (470M). APLS has higher revenues than CRSP: APLS (781M) vs CRSP (35M).
APLSCRSPAPLS / CRSP
Capitalization2.18B3.39B64%
EBITDA-154.53M-447.31M35%
Gain YTD-45.190-2.0832,169%
P/E RatioN/AN/A-
Revenue781M35M2,231%
Total Cash411M1.9B22%
Total Debt470M224M210%
FUNDAMENTALS RATINGS
APLS vs CRSP: Fundamental Ratings
APLS
CRSP
OUTLOOK RATING
1..100
6154
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
9376
P/E GROWTH RATING
1..100
10071
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLS's Valuation (67) in the Medical Distributors industry is in the same range as CRSP (67) in the Biotechnology industry. This means that APLS’s stock grew similarly to CRSP’s over the last 12 months.

APLS's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as CRSP (100) in the Biotechnology industry. This means that APLS’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (92) in the Biotechnology industry is in the same range as APLS (95) in the Medical Distributors industry. This means that CRSP’s stock grew similarly to APLS’s over the last 12 months.

CRSP's Price Growth Rating (76) in the Biotechnology industry is in the same range as APLS (93) in the Medical Distributors industry. This means that CRSP’s stock grew similarly to APLS’s over the last 12 months.

CRSP's P/E Growth Rating (71) in the Biotechnology industry is in the same range as APLS (100) in the Medical Distributors industry. This means that CRSP’s stock grew similarly to APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 23 days ago
82%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVTX10.88N/A
N/A
Hartford International Equity R5
ACFFX26.44N/A
N/A
Columbia Acorn International Sel Inst
FFIDX82.86N/A
N/A
Fidelity
GTTMX16.73N/A
N/A
Glenmede Total Market Plus Eq Ptf
FJACX9.67N/A
N/A
Fidelity Series Small Cap Discovery

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ROIV. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+0.69%
ROIV - APLS
48%
Loosely correlated
+2.98%
BEAM - APLS
44%
Loosely correlated
+3.87%
NTLA - APLS
42%
Loosely correlated
-2.65%
IGMS - APLS
41%
Loosely correlated
-4.79%
CRSP - APLS
40%
Loosely correlated
-1.76%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.76%
RXRX - CRSP
72%
Closely correlated
-0.89%
BEAM - CRSP
71%
Closely correlated
+3.87%
NTLA - CRSP
66%
Loosely correlated
-2.65%
PRME - CRSP
63%
Loosely correlated
+4.14%
ABCL - CRSP
62%
Loosely correlated
+0.79%
More